Detection of active caspase-3 after 24 h of karonudib treatment confirmed induction of apoptosis selectively in B-cell lymphoma cells, but not in normal B cells (Supplemental Fig. 1B). This evidence concerns the gene CASP3 and B-cell non-Hodgkin lymphoma.